Researchers at Johns Hopkins Medicine say they have created a laboratory-grown three-dimensional "organoid" model that is derived from human tissue and designed to advance understanding about how early stages of cancer develop at the gastroesophageal junction (GEJ) the point where the digestive system's food tube meets the stomach.
A biomarker panel used on tissue samples obtained via a swallowable capsule can detect esophageal squamous cell cancer (ESCC) and may be particularly useful where endoscopy is not widely available.
In a small but rigorous pilot study, Johns Hopkins Medicine researchers have shown that a novel, minimally invasive biomarker-based strategy they developed was 90% successful in detecting esophageal squamous cell carcinoma (ESCC), the predominant sub
Preliminary Study Shows Minimally Invasive Diagnostic Biomarker Strategy Successful miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.